Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Sell
22
DRPRY Quote, Financials, Valuation and Earnings
Last price:
$6.04
Seasonality move
:
15.06%
Day range:
$5.80 - $6.06
52-week range:
$5.80 - $10.40
Dividend yield:
5.95%
P/E ratio:
8.89x
P/S ratio:
0.97x
P/B ratio:
2.26x
Volume:
44.1K
Avg. volume:
425.2K
1-year change:
-31.04%
Market cap:
$55.1B
Revenue:
$43.9B
EPS (TTM):
$0.86
Analysts' Opinion
-
Consensus RatingDr. Ing. h.c. F. Porsche AG has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Dr. Ing. h.c. F. Porsche AG has an estimated downside of -- from its current price of $6.05.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $6.05.
Fair Value
-
According to the consensus of 0 analysts, Dr. Ing. h.c. F. Porsche AG has -- downside to fair value with a price target of -- per share.
DRPRY vs. S&P 500
-
Over the past 5 trading days, Dr. Ing. h.c. F. Porsche AG has underperformed the S&P 500 by -4.78% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Dr. Ing. h.c. F. Porsche AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Dr. Ing. h.c. F. Porsche AG revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Dr. Ing. h.c. F. Porsche AG reported revenues of $9.8B.
Earnings Growth
-
Dr. Ing. h.c. F. Porsche AG earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Dr. Ing. h.c. F. Porsche AG reported earnings per share of $0.11.
Enterprise value:
42.1B
EV / Invested capital:
--
Price / LTM sales:
0.97x
EV / EBIT:
5.54x
EV / Revenue:
0.98x
PEG ratio (5yr expected):
--
EV / Free cash flow:
20.69x
Price / Operating cash flow:
20.34x
Enterprise value / EBITDA:
3.61x
Gross Profit (TTM):
$12.1B
Return On Assets:
9.46%
Net Income Margin (TTM):
11.86%
Return On Equity:
22.74%
Return On Invested Capital:
19.34%
Operating Margin:
14.23%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Income Statement | ||||||
| Revenue | -- | $41.4B | $42.8B | $10.8B | $9.8B | |
| Gross Profit | -- | $11.7B | $12.1B | $3B | $2.5B | |
| Operating Income | -- | $7.3B | $7.1B | $2B | $1.4B | |
| EBITDA | -- | $11.2B | $11.7B | $2.7B | $2.4B | |
| Diluted EPS | -- | $1.06 | $0.86 | $0.17 | $0.11 | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | $19.7B | $22.2B | |
| Total Assets | -- | -- | -- | $50.3B | $56.1B | |
| Current Liabilities | -- | -- | -- | $14.5B | $15.2B | |
| Total Liabilities | -- | -- | -- | $30B | $31.8B | |
| Total Equity | -- | -- | -- | $20.3B | $24.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | $8.3B | $6.9B | $2.4B | $1.7B | |
| Cash From Investing | -- | -$7.4B | -$2.7B | $94.5M | -$1.3B | |
| Cash From Financing | -- | -$3.4B | $157.8M | -$4.2B | -$47.8M | |
| Free Cash Flow | -- | $3.5B | $2B | $1.5B | $342.2M | |
DRPRY
Sector
Market Cap
$55.1B
$485.3M
Price % of 52-Week High
58.15%
72.59%
Dividend Yield
5.95%
0%
Shareholder Yield
--
3.59%
1-Year Price Total Return
-31.04%
-11.94%
Beta (5-Year)
--
0.971
Dividend yield:
5.95%
Annualized payout:
$0.00
Payout ratio:
-64.64%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$6.10
200-day SMA
Sell
Level
$7.86
Bollinger Bands (100)
Sell
Level
6.47 - 7.65
Chaikin Money Flow
Buy
Level
4.2M
20-day SMA
Sell
Level
$6.19
Relative Strength Index (RSI14)
Sell
Level
37.11
ADX Line
Sell
Level
18.71
Williams %R
Neutral
Level
-61.25
50-day SMA
Sell
Level
$6.60
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Sell
Level
-6.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3793)
Buy
CA Score
(Annual)
Level (0.0658)
Buy
Beneish M-Score
(Annual)
Level (-2.4642)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.6304)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Porsche engineers and manufactures premium and luxury sports cars and sports crossovers. The Porsche brand is synonymous with motorsports, German engineering, and fast, fun to drive, sports cars. The firm also has a captive finance company that provides funding for dealers and customers. In 2023, there were over 320,000 Porsche vehicles delivered to customers with about 25% going to China, 32% to Europe, 27% to North America, and 16% to rest of world.
Stock Forecast FAQ
In the current month, DRPRY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DRPRY average analyst price target in the past 3 months is --.
-
Where Will Dr. Ing. h.c. F. Porsche AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Dr. Ing. h.c. F. Porsche AG share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Dr. Ing. h.c. F. Porsche AG?
Analysts are divided on their view about Dr. Ing. h.c. F. Porsche AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Dr. Ing. h.c. F. Porsche AG is a Sell and believe this share price will rise from its current level to --.
-
What Is Dr. Ing. h.c. F. Porsche AG's Price Target?
The price target for Dr. Ing. h.c. F. Porsche AG over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DRPRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Dr. Ing. h.c. F. Porsche AG is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of DRPRY?
You can purchase shares of Dr. Ing. h.c. F. Porsche AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Dr. Ing. h.c. F. Porsche AG shares.
-
What Is The Dr. Ing. h.c. F. Porsche AG Share Price Today?
Dr. Ing. h.c. F. Porsche AG was last trading at $6.04 per share. This represents the most recent stock quote for Dr. Ing. h.c. F. Porsche AG. Yesterday, Dr. Ing. h.c. F. Porsche AG closed at $6.05 per share.
-
How To Buy Dr. Ing. h.c. F. Porsche AG Stock Online?
In order to purchase Dr. Ing. h.c. F. Porsche AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
